enVVeno Medical (NVNO) Research & Development (2017 - 2026)

enVVeno Medical's Research & Development history runs 10 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• On a quarterly basis, Research & Development fell 17.44% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 18.88% decrease from a year earlier, with the FY2025 full-year figure at $10.0 million, down 18.52% from the prior year.
• Research & Development climbed to $2.1 million in Q1 2026 per NVNO's latest filing, from $1.9 million in the prior quarter.
• Across five years, Research & Development topped out at $4.2 million in Q2 2023 and bottomed at $1.6 million in Q1 2022.
• The 5-year median for Research & Development is $2.8 million (2024), against an average of $2.8 million.
• Across the five-year window, Research & Development surged 181.93% in 2022 and slumped 44.55% in 2025, its largest moves.
• Year by year, Research & Development stood at $2.8 million in 2022, then increased by 6.58% to $3.0 million in 2023, then increased by 17.85% to $3.5 million in 2024, then slumped by 44.55% to $1.9 million in 2025, then rose by 8.37% to $2.1 million in 2026.
• Per Business Quant, the three latest NVNO Research & Development figures stand at $2.1 million (Q1 2026), $1.9 million (Q4 2025), and $2.6 million (Q3 2025).